![Matteo Levisetti](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matteo Levisetti
Geen lopende functies
Vermogen: 9 720 $ op 30-06-2026
Profiel
Matteo Levisetti worked as Executive Director-Clinical Development at Mirati Therapeutics, Inc. from 2016 to 2017.
Served as Chief Medical Officer at Dauntless Pharmaceuticals, Inc. from 2017 to 2018.
Held the position of Chief Medical Officer at DNAtrix, Inc. from 2019 to 2021.
Worked as Chief Medical Officer at Cue Biopharma, Inc. from 2023 to 2025.
Held the role of Global Head & VP-Translational Medicine at Roche Pharmaceuticals, Inc. Worked as Assistant Professor at Washington University School of Medicine.
Education includes a doctorate degree from Pritzker School of Medicine conferred in 1996.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CUE BIOPHARMA, INC. 0,01% | 05-05-2026 | 308 ( 0,01% ) | 9 720 $ | 30-06-2026 |
Eerdere bekende functies van Matteo Levisetti
| Bedrijven | Functie | Einde |
|---|---|---|
| CUE BIOPHARMA, INC. | Hoofd Techniek/Wetenschap/O&O | 28-11-2025 |
DNAtrix, Inc.
 DNAtrix, Inc. Electronic Equipment/InstrumentsElectronic Technology Operates as a biotech company which focuses on the development of oncolytic viruses for cancer | Hoofd Techniek/Wetenschap/O&O | 01-01-2021 |
Dauntless Pharmaceuticals, Inc.
 Dauntless Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Develops specialty drugs | Hoofd Techniek/Wetenschap/O&O | 01-06-2018 |
| MIRATI THERAPEUTICS | Hoofd Techniek/Wetenschap/O&O | 01-05-2017 |
Washington University School of Medicine
 Washington University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Opleiding van Matteo Levisetti
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
15
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
DNAtrix, Inc.
DNAtrix, Inc. Electronic Equipment/InstrumentsElectronic Technology Operates as a biotech company which focuses on the development of oncolytic viruses for cancer | Electronic Technology |
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
Pritzker School of Medicine
 Pritzker School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Washington University School of Medicine
Washington University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cue Biopharma, Inc.
 Cue Biopharma, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Dauntless Pharmaceuticals, Inc.
Dauntless Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Develops specialty drugs | Retail Trade |
Kies MarketScreener 
